Antidiabetic activity in human T2DM patients assessed as reduction in HbA1c level at 25 mg, po relative to control

Basic Information

ID: ALA4343603

Type: Functional

Description: Antidiabetic activity in human T2DM patients assessed as reduction in HbA1c level at 25 mg, po relative to control

Format: BAO_0000218

Organism: Homo sapiens

Target: Homo sapiens(ALA372)

Document: ALA4342422

Antidiabetic activity in human T2DM patients assessed as reduction in HbA1c level at 25 mg, po relative to control: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4343603

Activity

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
450.92	1.61	1.61

Parent Molecular Weight

ALogP

Polar Surface Area

450.92

1.61

Basic Information